261 related articles for article (PubMed ID: 27982424)
1. Knowledge insufficient: the management of haemoglobin SC disease.
Pecker LH; Schaefer BA; Luchtman-Jones L
Br J Haematol; 2017 Feb; 176(4):515-526. PubMed ID: 27982424
[TBL] [Abstract][Full Text] [Related]
2. Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS).
Ren H; Ghebremeskel K; Okpala I; Ugochukwu CC; Crawford M; Ibegbulam O
Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):1-6. PubMed ID: 16314081
[TBL] [Abstract][Full Text] [Related]
3. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
[TBL] [Abstract][Full Text] [Related]
4. Prospective identification of variables as outcomes for treatment (PIVOT): study protocol for a randomised, placebo-controlled trial of hydroxyurea for Ghanaian children and adults with haemoglobin SC disease.
Smart LR; Segbefia CI; Latham TS; Stuber SE; Amissah-Arthur KN; Dzefi-Tettey K; Lane AC; Dei-Adomakoh YA; Ware RE
Trials; 2023 Sep; 24(1):603. PubMed ID: 37737189
[TBL] [Abstract][Full Text] [Related]
5. The pattern of sickle cell disease in pregnancy in Lagos, Nigeria.
Ogedengbe OK; Akinyanju O
West Afr J Med; 1993; 12(2):96-100. PubMed ID: 8398940
[TBL] [Abstract][Full Text] [Related]
6. Novel permeability characteristics of red blood cells from sickle cell patients heterozygous for HbS and HbC (HbSC genotype).
Dalibalta S; Ellory JC; Browning JA; Wilkins RJ; Rees DC; Gibson JS
Blood Cells Mol Dis; 2010 Jun; 45(1):46-52. PubMed ID: 20227897
[TBL] [Abstract][Full Text] [Related]
7. Comparative studies of live neonates in maternal sickle cell haemoglobinopathy in Ghana.
Addai FK; Wilson JB; Quashie FJ
Trop Geogr Med; 1992 Oct; 44(4):312-6. PubMed ID: 1295139
[TBL] [Abstract][Full Text] [Related]
8. Total Serum Magnesium Levels and Calcium-To-Magnesium Ratio in Sickle Cell Disease.
Antwi-Boasiako C; Kusi-Mensah YA; Hayfron-Benjamin C; Aryee R; Dankwah GB; Kwawukume LA; Darkwa EO
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31470666
[No Abstract] [Full Text] [Related]
9. Original Research: Use of hydroxyurea and phlebotomy in pediatric patients with hemoglobin SC disease.
Summarell CC; Sheehan VA
Exp Biol Med (Maywood); 2016 Apr; 241(7):737-44. PubMed ID: 26993671
[TBL] [Abstract][Full Text] [Related]
10. Cation Homeostasis in Red Cells From Patients With Sickle Cell Disease Heterologous for HbS and HbC (HbSC Genotype).
Hannemann A; Rees DC; Tewari S; Gibson JS
EBioMedicine; 2015 Nov; 2(11):1669-76. PubMed ID: 26870793
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcome in patients with sickle cell disease in the UK--a national cohort study comparing sickle cell anaemia (HbSS) with HbSC disease.
Oteng-Ntim E; Ayensah B; Knight M; Howard J
Br J Haematol; 2015 Apr; 169(1):129-37. PubMed ID: 25522142
[TBL] [Abstract][Full Text] [Related]
12. The pleiotropic effects of α-thalassemia on HbSS and HbSC sickle cell disease: Reduced erythrocyte cation co-transport activity, serum erythropoietin, and transfusion burden, do not translate into increased survival.
Brewin JN; Nardo-Marino A; Stuart-Smith S; El Hoss S; Hanneman A; Strouboulis J; Menzel S; Gibson JS; Rees DC
Am J Hematol; 2022 Oct; 97(10):1275-1285. PubMed ID: 35802781
[TBL] [Abstract][Full Text] [Related]
13. Most adults with severe HbSC disease are not treated with hydroxyurea.
Ghunney WK; Asare EV; Ayete-Nyampong JB; Oppong SA; Rodeghier M; DeBaun MR; Olayemi E
Blood Adv; 2023 Jul; 7(13):3312-3319. PubMed ID: 36799926
[TBL] [Abstract][Full Text] [Related]
14. Binding of ovarian steroids to erythrocytes in patients with sickle cell disease; effects on cell sickling and osmotic fragility.
Yoong WC; Tuck SM; Michael AE
J Steroid Biochem Mol Biol; 2003 Jan; 84(1):71-8. PubMed ID: 12648526
[TBL] [Abstract][Full Text] [Related]
15. Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype.
Blann AD; Mohan JS; Bareford D; Lip GY
J Thromb Thrombolysis; 2008 Apr; 25(2):185-9. PubMed ID: 18080800
[TBL] [Abstract][Full Text] [Related]
16. The clinical spectrum of HbSC sickle cell disease-not a benign condition.
Nelson M; Noisette L; Pugh N; Gordeuk V; Hsu LL; Wun T; Shah N; Glassberg J; Kutlar A; Hankins JS; King AA; Brambilla D; Kanter J
Br J Haematol; 2024 Jun; ():. PubMed ID: 38898714
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for the management of sickle cell disease in South Africa.
Alli NA; Patel M; Alli HD; Bassa F; Coetzee MJ; Davidson A; Essop MR; Lakha A; Louw VJ; Novitzky N; Philip V; Poole JE; Wainwright RD
S Afr Med J; 2014 Nov; 104(11):743-51. PubMed ID: 25909112
[TBL] [Abstract][Full Text] [Related]
18. Blood film features of sickle cell-haemoglobin C disease.
Bain BJ
Br J Haematol; 1993 Mar; 83(3):516-8. PubMed ID: 8485058
[TBL] [Abstract][Full Text] [Related]
19. Platelet P-selectin and platelet mass, volume and component in sickle cell disease: relationship to genotype.
Mohan JS; Lip GY; Bareford D; Blann AD
Thromb Res; 2006; 117(6):623-9. PubMed ID: 16051315
[TBL] [Abstract][Full Text] [Related]
20. Hypodontia in an adolescent with the HbSC genotype: a case report.
Oredugba FA
Int J Paediatr Dent; 2005 Nov; 15(6):455-8. PubMed ID: 16238656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
